IFNG and tuberculosis: Previous studies have shown that DNA-based or rBCG vaccines encoding TB-Ag85A can generate responses which induce antigen-specific IFNγ+ T cell populations, circulating titers of anti-Ag85A IgG, and which reduce virulent M. tuberculosis burdens in murine lungs and spleens [43–46].